0 items USD 0.00Search
- Did you mean
- gene%etherapy
Your search for "Gene%2520Therapy" gave back 310262 results.
Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Drugs In Development, 2021 Summary Frataxin Mitochondrial (Friedreich...
Catalog:
Global Markets Direct
June 2021
Price: USD 3,500.00
Viruses have evolved to become highly efficient at nucleic acid delivery to specific cell types while avoiding immunosurveillance by an infected host...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Non-viral vectors for gene therapy are non-viral vehicles (particle based or chemical based) that deliver the genetic material into a wide variety of...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
Adeno-associated viruses (AAV) are small viruses that infect humans and some other primate species. They belong to the genus Dependoparvovirus, which...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Gene therapy is used for correcting defective genes that are responsible for disease development. Moreover, nucleic acid-based therapeutics are used...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Hepatocyte Growth Factor (Hepatopoietin A or Scatter Factor or HGF) - Pipeline Review, H1 2018 Summary Hepatocyte Growth Factor (Hepatopoietin A or...
Catalog:
Global Markets Direct
March 2018
Price: USD 3,500.00
Batten Disease - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Batten...
Catalog:
Global Markets Direct
February 2020
Price: USD 2,000.00
Viral vectors carry genetic material into cells by exploiting the molecular mechanisms by which viruses transmit their genomes to other cells for...
Catalog:
GIR
April 2023
Price: USD 3,480.00
Adeno-associated viruses (AAV) are small viruses that infect humans and some other primate species. They belong to the genus Dependoparvovirus, which...
Catalog:
MRRPB5
September 2023
Price: USD 4,900.00
Leber Congenital Amaurosis (LCA) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
Catalog:
Global Markets Direct
September 2018
Price: USD 2,000.00
Juvenile Macular Degeneration (Stargardt Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update...
Catalog:
Global Markets Direct
April 2022
Price: USD 2,000.00
Exosome Technologies: Recent Surge in R&D with Capricor, Codiak and Evox Therapeutics among Key Players Summary GBI Research’s latest report,...
Catalog:
CBR Pharma Insights
October 2018
Price: USD 2,995.00
Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Summary The Gene Therapies for Tumor Treatment market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx...
Catalog:
HYR
March 2021
Price: USD 2,000.00
Alpha N-Acetylglucosaminidase - Pipeline Review, H2 2019 Summary Alpha N-Acetylglucosaminidase (N Acetyl Alpha Glucosaminidase or NAGLU or EC 3.2.1...
Catalog:
Global Markets Direct
December 2019
Price: USD 3,500.00
